Disease Areas
Diabetes
Obesity
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Neurodegenerative Diseases
Haemophilia
Sickle Cell Disease
Primary Hyperoxaluria
Growth Hormone Disorders
Hormone Replacement Therapy
Congresses
Scientific Publications
IME
Register
Login
My Account
Welcome to Novo Nordisk Science Hub
Are you a healthcare professional?
No
Yes
Congresses
American Association for the Study of Liver Diseases, The Liver Meeting
Semaglutide improves liver enzymes and fatty liver index in patients with obesity and cardiovascular disease – results from the SELECT trial
American Association for the Study of Liver Diseases, The Liver Meeting
:
Download poster (.pdf)
{{ getPageNum(PDFPage) }}
